Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Glycogen Synthase Kinase 3 Beta Market Growth 2022-2028

  • LP 4922893
  • 95 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Glycogen Synthase Kinase 3 Beta will have significant change from previous year. According to our (LP Information) latest study, the global Glycogen Synthase Kinase 3 Beta market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Glycogen Synthase Kinase 3 Beta market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Glycogen Synthase Kinase 3 Beta market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Glycogen Synthase Kinase 3 Beta market, reaching US$ million by the year 2028. As for the Europe Glycogen Synthase Kinase 3 Beta landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Glycogen Synthase Kinase 3 Beta players cover Mitsubishi Tanabe Pharma Corp, Neurim Pharmaceuticals Ltd, Actuate Therapeutics Inc, and DiaMedica Therapeutics Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Glycogen Synthase Kinase 3 Beta market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

AP-001

AP-1

DM-204

Neu-120

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Musculoskeletal Disorder

Lung Cancer

Dyskinesia

Menkes Disease

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Mitsubishi Tanabe Pharma Corp

Neurim Pharmaceuticals Ltd

Actuate Therapeutics Inc

DiaMedica Therapeutics Inc

Angelini Group

Jeil Pharmaceutical Co Ltd

AMO Pharma Ltd

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Glycogen Synthase Kinase 3 Beta Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Glycogen Synthase Kinase 3 Beta by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Glycogen Synthase Kinase 3 Beta by Country/Region, 2017, 2022 & 2028

2.2 Glycogen Synthase Kinase 3 Beta Segment by Type

2.2.1 AP-001

2.2.2 AP-1

2.2.3 DM-204

2.2.4 Neu-120

2.2.5 Others

2.3 Glycogen Synthase Kinase 3 Beta Sales by Type

2.3.1 Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2017-2022)

2.3.2 Global Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Type (2017-2022)

2.3.3 Global Glycogen Synthase Kinase 3 Beta Sale Price by Type (2017-2022)

2.4 Glycogen Synthase Kinase 3 Beta Segment by Application

2.4.1 Musculoskeletal Disorder

2.4.2 Lung Cancer

2.4.3 Dyskinesia

2.4.4 Menkes Disease

2.4.5 Others

2.5 Glycogen Synthase Kinase 3 Beta Sales by Application

2.5.1 Global Glycogen Synthase Kinase 3 Beta Sale Market Share by Application (2017-2022)

2.5.2 Global Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Application (2017-2022)

2.5.3 Global Glycogen Synthase Kinase 3 Beta Sale Price by Application (2017-2022)

3 Global Glycogen Synthase Kinase 3 Beta by Company

3.1 Global Glycogen Synthase Kinase 3 Beta Breakdown Data by Company

3.1.1 Global Glycogen Synthase Kinase 3 Beta Annual Sales by Company (2020-2022)

3.1.2 Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Company (2020-2022)

3.2 Global Glycogen Synthase Kinase 3 Beta Annual Revenue by Company (2020-2022)

3.2.1 Global Glycogen Synthase Kinase 3 Beta Revenue by Company (2020-2022)

3.2.2 Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Company (2020-2022)

3.3 Global Glycogen Synthase Kinase 3 Beta Sale Price by Company

3.4 Key Manufacturers Glycogen Synthase Kinase 3 Beta Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Glycogen Synthase Kinase 3 Beta Product Location Distribution

3.4.2 Players Glycogen Synthase Kinase 3 Beta Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Glycogen Synthase Kinase 3 Beta by Geographic Region

4.1 World Historic Glycogen Synthase Kinase 3 Beta Market Size by Geographic Region (2017-2022)

4.1.1 Global Glycogen Synthase Kinase 3 Beta Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Glycogen Synthase Kinase 3 Beta Annual Revenue by Geographic Region

4.2 World Historic Glycogen Synthase Kinase 3 Beta Market Size by Country/Region (2017-2022)

4.2.1 Global Glycogen Synthase Kinase 3 Beta Annual Sales by Country/Region (2017-2022)

4.2.2 Global Glycogen Synthase Kinase 3 Beta Annual Revenue by Country/Region

4.3 Americas Glycogen Synthase Kinase 3 Beta Sales Growth

4.4 APAC Glycogen Synthase Kinase 3 Beta Sales Growth

4.5 Europe Glycogen Synthase Kinase 3 Beta Sales Growth

4.6 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales Growth

5 Americas

5.1 Americas Glycogen Synthase Kinase 3 Beta Sales by Country

5.1.1 Americas Glycogen Synthase Kinase 3 Beta Sales by Country (2017-2022)

5.1.2 Americas Glycogen Synthase Kinase 3 Beta Revenue by Country (2017-2022)

5.2 Americas Glycogen Synthase Kinase 3 Beta Sales by Type

5.3 Americas Glycogen Synthase Kinase 3 Beta Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Glycogen Synthase Kinase 3 Beta Sales by Region

6.1.1 APAC Glycogen Synthase Kinase 3 Beta Sales by Region (2017-2022)

6.1.2 APAC Glycogen Synthase Kinase 3 Beta Revenue by Region (2017-2022)

6.2 APAC Glycogen Synthase Kinase 3 Beta Sales by Type

6.3 APAC Glycogen Synthase Kinase 3 Beta Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Glycogen Synthase Kinase 3 Beta by Country

7.1.1 Europe Glycogen Synthase Kinase 3 Beta Sales by Country (2017-2022)

7.1.2 Europe Glycogen Synthase Kinase 3 Beta Revenue by Country (2017-2022)

7.2 Europe Glycogen Synthase Kinase 3 Beta Sales by Type

7.3 Europe Glycogen Synthase Kinase 3 Beta Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Glycogen Synthase Kinase 3 Beta by Country

8.1.1 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Country (2017-2022)

8.1.2 Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue by Country (2017-2022)

8.2 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Type

8.3 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Glycogen Synthase Kinase 3 Beta

10.3 Manufacturing Process Analysis of Glycogen Synthase Kinase 3 Beta

10.4 Industry Chain Structure of Glycogen Synthase Kinase 3 Beta

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Glycogen Synthase Kinase 3 Beta Distributors

11.3 Glycogen Synthase Kinase 3 Beta Customer

12 World Forecast Review for Glycogen Synthase Kinase 3 Beta by Geographic Region

12.1 Global Glycogen Synthase Kinase 3 Beta Market Size Forecast by Region

12.1.1 Global Glycogen Synthase Kinase 3 Beta Forecast by Region (2023-2028)

12.1.2 Global Glycogen Synthase Kinase 3 Beta Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Glycogen Synthase Kinase 3 Beta Forecast by Type

12.7 Global Glycogen Synthase Kinase 3 Beta Forecast by Application

13 Key Players Analysis

13.1 Mitsubishi Tanabe Pharma Corp

13.1.1 Mitsubishi Tanabe Pharma Corp Company Information

13.1.2 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Product Offered

13.1.3 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Mitsubishi Tanabe Pharma Corp Main Business Overview

13.1.5 Mitsubishi Tanabe Pharma Corp Latest Developments

13.2 Neurim Pharmaceuticals Ltd

13.2.1 Neurim Pharmaceuticals Ltd Company Information

13.2.2 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Product Offered

13.2.3 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Neurim Pharmaceuticals Ltd Main Business Overview

13.2.5 Neurim Pharmaceuticals Ltd Latest Developments

13.3 Actuate Therapeutics Inc

13.3.1 Actuate Therapeutics Inc Company Information

13.3.2 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Offered

13.3.3 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Actuate Therapeutics Inc Main Business Overview

13.3.5 Actuate Therapeutics Inc Latest Developments

13.4 DiaMedica Therapeutics Inc

13.4.1 DiaMedica Therapeutics Inc Company Information

13.4.2 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Offered

13.4.3 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 DiaMedica Therapeutics Inc Main Business Overview

13.4.5 DiaMedica Therapeutics Inc Latest Developments

13.5 Angelini Group

13.5.1 Angelini Group Company Information

13.5.2 Angelini Group Glycogen Synthase Kinase 3 Beta Product Offered

13.5.3 Angelini Group Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Angelini Group Main Business Overview

13.5.5 Angelini Group Latest Developments

13.6 Jeil Pharmaceutical Co Ltd

13.6.1 Jeil Pharmaceutical Co Ltd Company Information

13.6.2 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Product Offered

13.6.3 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Jeil Pharmaceutical Co Ltd Main Business Overview

13.6.5 Jeil Pharmaceutical Co Ltd Latest Developments

13.7 AMO Pharma Ltd

13.7.1 AMO Pharma Ltd Company Information

13.7.2 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Product Offered

13.7.3 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 AMO Pharma Ltd Main Business Overview

13.7.5 AMO Pharma Ltd Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Glycogen Synthase Kinase 3 Beta Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Glycogen Synthase Kinase 3 Beta Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of AP-001

Table 4. Major Players of AP-1

Table 5. Major Players of DM-204

Table 6. Major Players of Neu-120

Table 7. Major Players of Others

Table 8. Global Glycogen Synthase Kinase 3 Beta Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2017-2022)

Table 10. Global Glycogen Synthase Kinase 3 Beta Revenue by Type (2017-2022) & ($ million)

Table 11. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2017-2022)

Table 12. Global Glycogen Synthase Kinase 3 Beta Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Glycogen Synthase Kinase 3 Beta Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2017-2022)

Table 15. Global Glycogen Synthase Kinase 3 Beta Revenue by Application (2017-2022)

Table 16. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2017-2022)

Table 17. Global Glycogen Synthase Kinase 3 Beta Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Glycogen Synthase Kinase 3 Beta Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Company (2020-2022)

Table 20. Global Glycogen Synthase Kinase 3 Beta Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Company (2020-2022)

Table 22. Global Glycogen Synthase Kinase 3 Beta Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Glycogen Synthase Kinase 3 Beta Producing Area Distribution and Sales Area

Table 24. Players Glycogen Synthase Kinase 3 Beta Products Offered

Table 25. Glycogen Synthase Kinase 3 Beta Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Glycogen Synthase Kinase 3 Beta Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Glycogen Synthase Kinase 3 Beta Sales Market Share Geographic Region (2017-2022)

Table 30. Global Glycogen Synthase Kinase 3 Beta Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Glycogen Synthase Kinase 3 Beta Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Country/Region (2017-2022)

Table 34. Global Glycogen Synthase Kinase 3 Beta Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Glycogen Synthase Kinase 3 Beta Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2017-2022)

Table 38. Americas Glycogen Synthase Kinase 3 Beta Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country (2017-2022)

Table 40. Americas Glycogen Synthase Kinase 3 Beta Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2017-2022)

Table 42. Americas Glycogen Synthase Kinase 3 Beta Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2017-2022)

Table 44. APAC Glycogen Synthase Kinase 3 Beta Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Glycogen Synthase Kinase 3 Beta Sales Market Share by Region (2017-2022)

Table 46. APAC Glycogen Synthase Kinase 3 Beta Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Glycogen Synthase Kinase 3 Beta Revenue Market Share by Region (2017-2022)

Table 48. APAC Glycogen Synthase Kinase 3 Beta Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2017-2022)

Table 50. APAC Glycogen Synthase Kinase 3 Beta Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2017-2022)

Table 52. Europe Glycogen Synthase Kinase 3 Beta Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2017-2022)

Table 54. Europe Glycogen Synthase Kinase 3 Beta Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country (2017-2022)

Table 56. Europe Glycogen Synthase Kinase 3 Beta Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2017-2022)

Table 58. Europe Glycogen Synthase Kinase 3 Beta Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Glycogen Synthase Kinase 3 Beta

Table 69. Key Market Challenges & Risks of Glycogen Synthase Kinase 3 Beta

Table 70. Key Industry Trends of Glycogen Synthase Kinase 3 Beta

Table 71. Glycogen Synthase Kinase 3 Beta Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Glycogen Synthase Kinase 3 Beta Distributors List

Table 74. Glycogen Synthase Kinase 3 Beta Customer List

Table 75. Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Glycogen Synthase Kinase 3 Beta Sales Market Forecast by Region

Table 77. Global Glycogen Synthase Kinase 3 Beta Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Glycogen Synthase Kinase 3 Beta Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Glycogen Synthase Kinase 3 Beta Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Glycogen Synthase Kinase 3 Beta Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Glycogen Synthase Kinase 3 Beta Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Glycogen Synthase Kinase 3 Beta Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Glycogen Synthase Kinase 3 Beta Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Glycogen Synthase Kinase 3 Beta Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Glycogen Synthase Kinase 3 Beta Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share Forecast by Application (2023-2028)

Table 95. Mitsubishi Tanabe Pharma Corp Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors

Table 96. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Product Offered

Table 97. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Mitsubishi Tanabe Pharma Corp Main Business

Table 99. Mitsubishi Tanabe Pharma Corp Latest Developments

Table 100. Neurim Pharmaceuticals Ltd Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors

Table 101. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Product Offered

Table 102. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Neurim Pharmaceuticals Ltd Main Business

Table 104. Neurim Pharmaceuticals Ltd Latest Developments

Table 105. Actuate Therapeutics Inc Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors

Table 106. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Offered

Table 107. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Actuate Therapeutics Inc Main Business

Table 109. Actuate Therapeutics Inc Latest Developments

Table 110. DiaMedica Therapeutics Inc Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors

Table 111. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Offered

Table 112. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. DiaMedica Therapeutics Inc Main Business

Table 114. DiaMedica Therapeutics Inc Latest Developments

Table 115. Angelini Group Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors

Table 116. Angelini Group Glycogen Synthase Kinase 3 Beta Product Offered

Table 117. Angelini Group Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Angelini Group Main Business

Table 119. Angelini Group Latest Developments

Table 120. Jeil Pharmaceutical Co Ltd Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors

Table 121. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Product Offered

Table 122. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Jeil Pharmaceutical Co Ltd Main Business

Table 124. Jeil Pharmaceutical Co Ltd Latest Developments

Table 125. AMO Pharma Ltd Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors

Table 126. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Product Offered

Table 127. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. AMO Pharma Ltd Main Business

Table 129. AMO Pharma Ltd Latest Developments

List of Figures

Figure 1. Picture of Glycogen Synthase Kinase 3 Beta

Figure 2. Glycogen Synthase Kinase 3 Beta Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Glycogen Synthase Kinase 3 Beta Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Glycogen Synthase Kinase 3 Beta Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Glycogen Synthase Kinase 3 Beta Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of AP-001

Figure 10. Product Picture of AP-1

Figure 11. Product Picture of DM-204

Figure 12. Product Picture of Neu-120

Figure 13. Product Picture of Others

Figure 14. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type in 2021

Figure 15. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2017-2022)

Figure 16. Glycogen Synthase Kinase 3 Beta Consumed in Musculoskeletal Disorder

Figure 17. Global Glycogen Synthase Kinase 3 Beta Market: Musculoskeletal Disorder (2017-2022) & (K Pcs)

Figure 18. Glycogen Synthase Kinase 3 Beta Consumed in Lung Cancer

Figure 19. Global Glycogen Synthase Kinase 3 Beta Market: Lung Cancer (2017-2022) & (K Pcs)

Figure 20. Glycogen Synthase Kinase 3 Beta Consumed in Dyskinesia

Figure 21. Global Glycogen Synthase Kinase 3 Beta Market: Dyskinesia (2017-2022) & (K Pcs)

Figure 22. Glycogen Synthase Kinase 3 Beta Consumed in Menkes Disease

Figure 23. Global Glycogen Synthase Kinase 3 Beta Market: Menkes Disease (2017-2022) & (K Pcs)

Figure 24. Glycogen Synthase Kinase 3 Beta Consumed in Others

Figure 25. Global Glycogen Synthase Kinase 3 Beta Market: Others (2017-2022) & (K Pcs)

Figure 26. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2017-2022)

Figure 27. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application in 2021

Figure 28. Glycogen Synthase Kinase 3 Beta Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Company in 2021

Figure 30. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Geographic Region in 2021

Figure 32. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Region (2017-2022)

Figure 33. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country/Region in 2021

Figure 34. Americas Glycogen Synthase Kinase 3 Beta Sales 2017-2022 (K Pcs)

Figure 35. Americas Glycogen Synthase Kinase 3 Beta Revenue 2017-2022 ($ Millions)

Figure 36. APAC Glycogen Synthase Kinase 3 Beta Sales 2017-2022 (K Pcs)

Figure 37. APAC Glycogen Synthase Kinase 3 Beta Revenue 2017-2022 ($ Millions)

Figure 38. Europe Glycogen Synthase Kinase 3 Beta Sales 2017-2022 (K Pcs)

Figure 39. Europe Glycogen Synthase Kinase 3 Beta Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales 2017-2022 (K Pcs)

Figure 41. Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue 2017-2022 ($ Millions)

Figure 42. Americas Glycogen Synthase Kinase 3 Beta Sales Market Share by Country in 2021

Figure 43. Americas Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country in 2021

Figure 44. United States Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Glycogen Synthase Kinase 3 Beta Sales Market Share by Region in 2021

Figure 49. APAC Glycogen Synthase Kinase 3 Beta Revenue Market Share by Regions in 2021

Figure 50. China Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Country in 2021

Figure 57. Europe Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country in 2021

Figure 58. Germany Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country in 2021

Figure 65. Egypt Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Glycogen Synthase Kinase 3 Beta Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Glycogen Synthase Kinase 3 Beta in 2021

Figure 71. Manufacturing Process Analysis of Glycogen Synthase Kinase 3 Beta

Figure 72. Industry Chain Structure of Glycogen Synthase Kinase 3 Beta

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390